title: Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection.
abstract: Two non-pathogenic scaffolds (represented by the filamentous bacteriophage fd and the dihydrolipoyl acetyltransferase E2 protein of the Bacillus stearothermophilus pyruvate dehydrogenase (PDH) complex) able to deliver human immunodeficiency virus (HIV)-1 antigenic determinants, were designed in our laboratories and investigated in controlled assay conditions. Based on a modification of the phage display technology, we developed an innovative concept for a safe and inexpensive vaccine in which conserved antigenic determinants of HIV-1 reverse transcriptase (RTase) were inserted into the N-terminal region of the major pVIII coat protein of bacteriophagefd virions. Analogously, we developed another antigen delivery system based on the E2 component from the PDH complex and capable of displaying large intact proteins on the surface of an icosahedral lattice. Our data show that both of these systems can deliver B and T epitopes to their respective presentation compartments in target cells and trigger a humoral response as well as a potent helper and cytolytic response in vitro and in vivo.
authors.affiliation: Institute of Protein Biochemistry, CNR, Naples, Italy. deberard@dafne.ibpe.na.cnr.it
authors.forename: Piergiuseppe
authors.initials: P
authors.lastname: De Berardinis
authors.forename: Rossella
authors.initials: R
authors.lastname: Sartorius
authors.forename: Antonella
authors.initials: A
authors.lastname: Caivano
authors.forename: Dina
authors.initials: D
authors.lastname: Mascolo
authors.forename: Gonzalo J
authors.initials: GJ
authors.lastname: Domingo
authors.forename: Giovanna
authors.initials: G
authors.lastname: Del Pozzo
authors.forename: Muriel
authors.initials: M
authors.lastname: Gaubin
authors.forename: Richard N
authors.initials: RN
authors.lastname: Perham
authors.forename: Dominique
authors.initials: D
authors.lastname: Piatier-Tonneau
authors.forename: John
authors.initials: J
authors.lastname: Guardiola
mesh_terms: D016915:AIDS Vaccines / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D000123:Acetyltransferases / Q000235:genetics / Q000276:immunology; D000818:Animals; D001426:Bacterial Proteins; D036022:Capsid Proteins / Q000235:genetics / Q000276:immunology; D051047:Dihydrolipoyllysine-Residue Acetyltransferase; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000517:prevention & control / Q000628:therapy; D054303:HIV Reverse Transcriptase / Q000235:genetics / Q000276:immunology*; D006801:Humans; D019151:Peptide Library; D011768:Pyruvate Dehydrogenase Complex / Q000235:genetics / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use
chemical_list: D016915:AIDS Vaccines; D001426:Bacterial Proteins; D036022:Capsid Proteins; D000939:Epitopes; D019151:Peptide Library; D011768:Pyruvate Dehydrogenase Complex; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; C119217:coat protein pVIII, Enterobacteria phage fd; D000123:Acetyltransferases; D051047:Dihydrolipoyllysine-Residue Acetyltransferase; D054303:HIV Reverse Transcriptase